Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03443453 · ClinicalTrials.gov registry record · Phase 1
A Bioavailability Study of MIV-711 Oral Formulations in Healthy Volunteers
A Phase 1 study, sponsored by Medivir.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT03443453 is a Phase 1 study that has completed, run by Medivir. The registered enrollment target is 18 participants.
The verdict
NCT03443453, a Phase 1 study, has completed, sponsored by Medivir.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
This is a single-Center, Randomised, 4-Period, Phase 1 Study to Evaluate the Pharmacokinetics, Safety and Tolerability, and Effect of Food on Pharmacokinetics following Single Doses of MIV-711 Capsule and Tablet Formulations in Healthy Volunteers
Interventions
- DRUG MIV-711
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-01-19 |
| Est. Completion | 2018-02-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03443453
The ClinicalTrials.gov registry entry for NCT03443453 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medivir, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MIV-711 is the first listed.
NCT03443453 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03443453 about?
NCT03443453 is a clinical study titled "A Bioavailability Study of MIV-711 Oral Formulations in Healthy Volunteers". This is a single-Center, Randomised, 4-Period, Phase 1 Study to Evaluate the Pharmacokinetics, Safety and Tolerability, and Effect of Food on Pharmacokinetics following Single Doses of MIV-711 Capsule and Tablet Formulations in Healthy Volunteers
What is the current status of trial NCT03443453?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2018-01-19. Estimated completion is 2018-02-17.
What interventions are being tested in trial NCT03443453?
The interventions under investigation include: MIV-711 (DRUG).
Who is sponsoring clinical trial NCT03443453?
This trial is sponsored by Medivir, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.